Amphotericin B (Conventional) and Ziprasidone Injection
Determining the interaction of Amphotericin B (Conventional) and Ziprasidone Injection and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Using ziprasidone together with amphotericin B can increase the risk of an irregular heart rhythm that may be serious. If your doctor prescribes these medications together, you may need regular monitoring of your electrolyte (magnesium, potassium) levels as well as other tests to safely use both medications. You should seek immediate medical attention if you develop sudden dizziness, lightheadedness, fainting, or fast or pounding heartbeats during treatment with ziprasidone. In addition, you should let your doctor know if you experience signs of electrolyte disturbance such as weakness, tiredness, drowsiness, confusion, muscle pain, cramps, dizziness, nausea, or vomiting. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:MONITOR CLOSELY: Ziprasidone can cause dose-related prolongation of the QT interval. While clinical data are lacking, the coadministration of ziprasidone and agents that can produce hypokalemia and/or hypomagnesemia (e.g., potassium-wasting diuretics, amphotericin B, cation exchange resins) may result in elevated risk of ventricular arrhythmias, including ventricular tachycardia and torsade de pointes, because of additive arrhythmogenic potential.
MANAGEMENT: Caution is advised when ziprasidone must be used concomitantly with medications that can cause potassium and/or magnesium disturbances. Serum electrolytes should be monitored and any abnormalities corrected prior to initiating therapy with ziprasidone. Patients should be advised to notify their physician if they experience possible signs of an electrolyte imbalance, such as weakness, lethargy, drowsiness, confusion, muscle pains or cramps, dizziness, nausea, vomiting, tachycardia, or an irregular heartbeat.
- "Product Information. Geodon (ziprasidone)." Pfizer US Pharmaceuticals, New York, NY.
Generic Name: amphotericin b
Brand name: Fungizone, Fungizone For Tissue Culture, Amphocin
Synonyms: Amphotericin B
Generic Name: ziprasidone
Brand name: Geodon
Synonyms: Ziprasidone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Amphotericin B (Conventional)-Ziprasidone Intramuscular
- Amphotericin B (Conventional)-Zipsor
- Amphotericin B (Conventional)-Zithromax
- Amphotericin B (Conventional)-Zithromax (Azithromycin Injection)
- Amphotericin B (Conventional)-Zithromax (Azithromycin Oral Suspension)
- Amphotericin B (Conventional)-Zithromax (Azithromycin Single-Dose Packet)
- Ziprasidone Injection-Amphotericin B (Lipid Complex)
- Ziprasidone Injection-Amphotericin B Cholesteryl Sulfate Complex
- Ziprasidone Injection-Amphotericin b cholesteryl sulfate complex Intravenous
- Ziprasidone Injection-Amphotericin b Intravenous, Injection
- Ziprasidone Injection-Amphotericin b lipid complex Intravenous, Injection
- Ziprasidone Injection-Amphotericin B liposomal